Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Identification of PMN-released mutagenic factors in a co-culture model for colitis-associated cancer.

Granofszky N, Lang M, Khare V, Schmid G, Scharl T, Ferk F, Jimenez K, Knasmüller S, Campregher C, Gasche C.

Carcinogenesis. 2018 Feb 9;39(2):146-157. doi: 10.1093/carcin/bgx118.

2.

Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice.

Kortüm B, Campregher C, Lang M, Khare V, Pinter M, Evstatiev R, Schmid G, Mittlböck M, Scharl T, Kucherlapati MH, Edelmann W, Gasche C.

Gut. 2015 Dec;64(12):1905-12. doi: 10.1136/gutjnl-2014-307663. Epub 2014 Nov 26.

3.

Modulation of N-glycosylation by mesalamine facilitates membranous E-cadherin expression in colon epithelial cells.

Khare V, Lang M, Dammann K, Campregher C, Lyakhovich A, Gasche C.

Biochem Pharmacol. 2014 Jan 15;87(2):312-20. doi: 10.1016/j.bcp.2013.10.021. Epub 2013 Oct 30.

4.

The interaction of endothelin-1 and TGF-β1 mediates vascular cell remodeling.

Lambers C, Roth M, Zhong J, Campregher C, Binder P, Burian B, Petkov V, Block LH.

PLoS One. 2013 Aug 28;8(8):e73399. doi: 10.1371/journal.pone.0073399. eCollection 2013.

5.

[Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].

Angelberger S, Campregher C, Fuchssteiner H, Gasche C, Gröchenig HP, Haas T, Kazemi-Shirazi L, Mayer A, Miehsler W, Platzer R, Reinisch W, Steiner P, Tilg H, Tillinger W, Vogelsang H, Novacek G.

Z Gastroenterol. 2013 May;51(5):450-7. doi: 10.1055/s-0033-1335252. Epub 2013 May 16. German.

PMID:
23681899
6.

Thymoquinone attenuates tumor growth in ApcMin mice by interference with Wnt-signaling.

Lang M, Borgmann M, Oberhuber G, Evstatiev R, Jimenez K, Dammann KW, Jambrich M, Khare V, Campregher C, Ristl R, Gasche C.

Mol Cancer. 2013 May 13;12(1):41. doi: 10.1186/1476-4598-12-41.

7.

MSH3-deficiency initiates EMAST without oncogenic transformation of human colon epithelial cells.

Campregher C, Schmid G, Ferk F, Knasmüller S, Khare V, Kortüm B, Dammann K, Lang M, Scharl T, Spittler A, Roig AI, Shay JW, Gerner C, Gasche C.

PLoS One. 2012;7(11):e50541. doi: 10.1371/journal.pone.0050541. Epub 2012 Nov 27.

8.

Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1.

Khare V, Lyakhovich A, Dammann K, Lang M, Borgmann M, Tichy B, Pospisilova S, Luciani G, Campregher C, Evstatiev R, Pflueger M, Hundsberger H, Gasche C.

Biochem Pharmacol. 2013 Jan 15;85(2):234-44. doi: 10.1016/j.bcp.2012.10.026. Epub 2012 Nov 9.

9.

Improvement of replication fidelity by certain mesalazine derivatives.

Honeder C, Campregher C, Zens B, Scharl T, Gasche C.

Int J Oncol. 2012 May;40(5):1331-8. doi: 10.3892/ijo.2012.1381. Epub 2012 Feb 21.

PMID:
22366868
10.

Aminosalicylates.

Campregher C, Gasche C.

Best Pract Res Clin Gastroenterol. 2011 Aug;25(4-5):535-46. doi: 10.1016/j.bpg.2011.10.013. Review.

PMID:
22122769
11.

An intracytoplasmic IL-10 receptor variant permits rapid reduction in STAT3 activation.

Finsterbusch M, Khare V, Campregher C, Evstatiev R, Gasche C.

Genes Immun. 2011 Oct;12(7):575-81. doi: 10.1038/gene.2011.12. Epub 2011 Jun 9.

12.

The nucleotide composition of microsatellites impacts both replication fidelity and mismatch repair in human colorectal cells.

Campregher C, Scharl T, Nemeth M, Honeder C, Jascur T, Boland CR, Gasche C.

Hum Mol Genet. 2010 Jul 1;19(13):2648-57. doi: 10.1093/hmg/ddq175. Epub 2010 Apr 26.

13.

Mesalazine reduces mutations in transforming growth factor beta receptor II and activin type II receptor by improvement of replication fidelity in mononucleotide repeats.

Campregher C, Honeder C, Chung H, Carethers JM, Gasche C.

Clin Cancer Res. 2010 Mar 15;16(6):1950-6. doi: 10.1158/1078-0432.CCR-09-2854. Epub 2010 Mar 2.

14.

The position of the amino group on the benzene ring is critical for mesalamine's improvement of replication fidelity.

Campregher C, Luciani MG, Biesenbach P, Evstatiev R, Lyakhovich A, Gasche C.

Inflamm Bowel Dis. 2010 Apr;16(4):576-82. doi: 10.1002/ibd.21112.

PMID:
19821510
15.

Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13-repeat in colon epithelial cells.

Campregher C, Luciani MG, Gasche C.

Gut. 2008 Jun;57(6):780-7. doi: 10.1136/gut.2007.141556. Epub 2008 Feb 13.

16.

Aspirin blocks proliferation in colon cells by inducing a G1 arrest and apoptosis through activation of the checkpoint kinase ATM.

Luciani MG, Campregher C, Gasche C.

Carcinogenesis. 2007 Oct;28(10):2207-17. Epub 2007 May 17.

PMID:
17510082
17.

5-ASA affects cell cycle progression in colorectal cells by reversibly activating a replication checkpoint.

Luciani MG, Campregher C, Fortune JM, Kunkel TA, Gasche C.

Gastroenterology. 2007 Jan;132(1):221-35. Epub 2006 Oct 12.

18.

[Disgerminoma of the ovary. Anatomo-prognostic correlations in 26 cases].

Pellegri PP, Boselli F, Grisanti M, Campregher C, Veratti M, Saletti C.

Ann Ostet Ginecol Med Perinat. 1981 Jul-Aug;102(4):291-6. Italian. No abstract available.

PMID:
7316360

Supplemental Content

Loading ...
Support Center